Leiden, January 5, 2010 – Cell Signaling Technology Europe B.V. has started operations on January 1st, 2010. Cell Signaling Technology Europe B.V. located in Leiden, The Netherlands, is the new wholly owned subsidiary of Cell Signaling Technology Inc. (CST), a leading manufacturer and distributor of antibodies and related reagent products for biomedical research.

“We are excited to finally be operating and look forward to a successful partnership with our European customers”, says Cell Signaling Technology Europe General Manager, Kees van den Berg. “The new regional office will provide Cell Signaling Technology customers state-of-art technical support and after sales services and will serve as a logistic center for its distributors in the European countries.”

With unique challenges and growth opportunities in each European country, Cell Signaling Technology Europe B.V. will work to enhance brand value, strengthen customer relationships and expand the scale of the business through marketing that is closely tailored to the European market.

For more information contact:
Cell Signaling Technology Europe B.V.
Mr. K. van den Berg
General Manager